{"id":8579,"date":"2025-12-25T08:25:34","date_gmt":"2025-12-25T08:25:34","guid":{"rendered":"https:\/\/gospeltodaynews.com\/?p=8579"},"modified":"2025-12-29T02:55:36","modified_gmt":"2025-12-29T02:55:36","slug":"compounded-semaglutide17896423-2","status":"publish","type":"post","link":"https:\/\/gospeltodaynews.com\/?p=8579","title":{"rendered":"Compounded Semaglutide17896423"},"content":{"rendered":"<div style=\"margin-top: 0px; margin-bottom: 0px;\" class=\"sharethis-inline-share-buttons\" ><\/div><p>Appropriate studies performed to date have not demonstrated geriatric-specific problems that would limit the usefulness of semaglutide injection in the elderly. However, elderly patients are more sensitive to the effects of this medicine than younger adults. NiceRx offers a one-month supply of compounded semaglutide including free shipping to your doorstep.<\/p>\n<ul>\n<li>Compounded semaglutide is more affordable, depending on where your prescription is filled.<\/li>\n<li>That&#039;s a big change over how this platform used to work; we saw previous customers mentioning sign-up fees of $1,000 to $2,000 for a year-long program and being charged immediately.<\/li>\n<li>Medicare and Medicaid typically only provide coverage for medications like Ozempic when they are used to treat conditions such as Type 2 diabetes &mdash; not for weight management.<\/li>\n<li>Wegovy&reg; is an injectable GLP-1 receptor agonist medication that is FDA-approved for weight loss in adults with obesity or overweight who have at least one weight-related condition.<\/li>\n<li>Your compounded semaglutide should be safe if it is made by a state-licensed compounding pharmacy that complies with state and FDA regulations.<\/li>\n<li>But semaglutide &mdash; the active pharmaceutical ingredient in Wegovy &mdash; is widely available, says Scott Brunner, CEO of the Alliance for Pharmacy Compounding.<\/li>\n<\/ul>\n<p>&nbsp;<\/p>\n<div style=\"margin-top: 0px; margin-bottom: 0px;\" class=\"sharethis-inline-share-buttons\" ><\/div>","protected":false},"excerpt":{"rendered":"<p>Appropriate studies performed to date have not demonstrated geriatric-specific problems that would limit the usefulness of semaglutide injection in the elderly. However, elderly patients are more sensitive to the effects of this medicine than younger adults. NiceRx offers a one-month supply of compounded semaglutide including free shipping to your doorstep. Compounded semaglutide is more affordable, [&hellip;]<\/p>\n<div style=\"margin-top: 0px; margin-bottom: 0px;\" class=\"sharethis-inline-share-buttons\" data-url=https:\/\/gospeltodaynews.com\/?p=8579><\/div>\n","protected":false},"author":8,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[1],"tags":[],"class_list":["post-8579","post","type-post","status-publish","format-standard","hentry","category-abahanzi"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.6 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Compounded Semaglutide17896423 - Gospel Today<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/gospeltodaynews.com\/?p=8579\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Compounded Semaglutide17896423 - Gospel Today\" \/>\n<meta property=\"og:description\" content=\"Appropriate studies performed to date have not demonstrated geriatric-specific problems that would limit the usefulness of semaglutide injection in the elderly. However, elderly patients are more sensitive to the effects of this medicine than younger adults. NiceRx offers a one-month supply of compounded semaglutide including free shipping to your doorstep. Compounded semaglutide is more affordable, [&hellip;]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/gospeltodaynews.com\/?p=8579\" \/>\n<meta property=\"og:site_name\" content=\"Gospel Today\" \/>\n<meta property=\"article:published_time\" content=\"2025-12-25T08:25:34+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2025-12-29T02:55:36+00:00\" \/>\n<meta name=\"author\" content=\"Nindenkayo Samuel\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Nindenkayo Samuel\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/gospeltodaynews.com\\\/?p=8579#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/gospeltodaynews.com\\\/?p=8579\"},\"author\":{\"name\":\"Nindenkayo Samuel\",\"@id\":\"https:\\\/\\\/gospeltodaynews.com\\\/#\\\/schema\\\/person\\\/74c1632b3310826292469c60b1e1739d\"},\"headline\":\"Compounded Semaglutide17896423\",\"datePublished\":\"2025-12-25T08:25:34+00:00\",\"dateModified\":\"2025-12-29T02:55:36+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/gospeltodaynews.com\\\/?p=8579\"},\"wordCount\":194,\"commentCount\":0,\"articleSection\":[\"ABAHANZI\"],\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\\\/\\\/gospeltodaynews.com\\\/?p=8579#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/gospeltodaynews.com\\\/?p=8579\",\"url\":\"https:\\\/\\\/gospeltodaynews.com\\\/?p=8579\",\"name\":\"Compounded Semaglutide17896423 - Gospel Today\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/gospeltodaynews.com\\\/#website\"},\"datePublished\":\"2025-12-25T08:25:34+00:00\",\"dateModified\":\"2025-12-29T02:55:36+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/gospeltodaynews.com\\\/#\\\/schema\\\/person\\\/74c1632b3310826292469c60b1e1739d\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/gospeltodaynews.com\\\/?p=8579#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/gospeltodaynews.com\\\/?p=8579\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/gospeltodaynews.com\\\/?p=8579#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/gospeltodaynews.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Compounded Semaglutide17896423\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/gospeltodaynews.com\\\/#website\",\"url\":\"https:\\\/\\\/gospeltodaynews.com\\\/\",\"name\":\"Gospel Today\",\"description\":\"\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/gospeltodaynews.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/gospeltodaynews.com\\\/#\\\/schema\\\/person\\\/74c1632b3310826292469c60b1e1739d\",\"name\":\"Nindenkayo Samuel\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/1668252a886d9c5e226132b82a7fe766fb4319fd75ecf73db16f3c009d30b482?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/1668252a886d9c5e226132b82a7fe766fb4319fd75ecf73db16f3c009d30b482?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/1668252a886d9c5e226132b82a7fe766fb4319fd75ecf73db16f3c009d30b482?s=96&d=mm&r=g\",\"caption\":\"Nindenkayo Samuel\"},\"sameAs\":[\"https:\\\/\\\/gospeltodaynews.com\\\/\"],\"url\":\"https:\\\/\\\/gospeltodaynews.com\\\/?author=8\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Compounded Semaglutide17896423 - Gospel Today","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/gospeltodaynews.com\/?p=8579","og_locale":"en_US","og_type":"article","og_title":"Compounded Semaglutide17896423 - Gospel Today","og_description":"Appropriate studies performed to date have not demonstrated geriatric-specific problems that would limit the usefulness of semaglutide injection in the elderly. However, elderly patients are more sensitive to the effects of this medicine than younger adults. NiceRx offers a one-month supply of compounded semaglutide including free shipping to your doorstep. Compounded semaglutide is more affordable, [&hellip;]","og_url":"https:\/\/gospeltodaynews.com\/?p=8579","og_site_name":"Gospel Today","article_published_time":"2025-12-25T08:25:34+00:00","article_modified_time":"2025-12-29T02:55:36+00:00","author":"Nindenkayo Samuel","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Nindenkayo Samuel","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/gospeltodaynews.com\/?p=8579#article","isPartOf":{"@id":"https:\/\/gospeltodaynews.com\/?p=8579"},"author":{"name":"Nindenkayo Samuel","@id":"https:\/\/gospeltodaynews.com\/#\/schema\/person\/74c1632b3310826292469c60b1e1739d"},"headline":"Compounded Semaglutide17896423","datePublished":"2025-12-25T08:25:34+00:00","dateModified":"2025-12-29T02:55:36+00:00","mainEntityOfPage":{"@id":"https:\/\/gospeltodaynews.com\/?p=8579"},"wordCount":194,"commentCount":0,"articleSection":["ABAHANZI"],"inLanguage":"en-US","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/gospeltodaynews.com\/?p=8579#respond"]}]},{"@type":"WebPage","@id":"https:\/\/gospeltodaynews.com\/?p=8579","url":"https:\/\/gospeltodaynews.com\/?p=8579","name":"Compounded Semaglutide17896423 - Gospel Today","isPartOf":{"@id":"https:\/\/gospeltodaynews.com\/#website"},"datePublished":"2025-12-25T08:25:34+00:00","dateModified":"2025-12-29T02:55:36+00:00","author":{"@id":"https:\/\/gospeltodaynews.com\/#\/schema\/person\/74c1632b3310826292469c60b1e1739d"},"breadcrumb":{"@id":"https:\/\/gospeltodaynews.com\/?p=8579#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/gospeltodaynews.com\/?p=8579"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/gospeltodaynews.com\/?p=8579#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/gospeltodaynews.com\/"},{"@type":"ListItem","position":2,"name":"Compounded Semaglutide17896423"}]},{"@type":"WebSite","@id":"https:\/\/gospeltodaynews.com\/#website","url":"https:\/\/gospeltodaynews.com\/","name":"Gospel Today","description":"","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/gospeltodaynews.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/gospeltodaynews.com\/#\/schema\/person\/74c1632b3310826292469c60b1e1739d","name":"Nindenkayo Samuel","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/1668252a886d9c5e226132b82a7fe766fb4319fd75ecf73db16f3c009d30b482?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/1668252a886d9c5e226132b82a7fe766fb4319fd75ecf73db16f3c009d30b482?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/1668252a886d9c5e226132b82a7fe766fb4319fd75ecf73db16f3c009d30b482?s=96&d=mm&r=g","caption":"Nindenkayo Samuel"},"sameAs":["https:\/\/gospeltodaynews.com\/"],"url":"https:\/\/gospeltodaynews.com\/?author=8"}]}},"_links":{"self":[{"href":"https:\/\/gospeltodaynews.com\/index.php?rest_route=\/wp\/v2\/posts\/8579","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/gospeltodaynews.com\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/gospeltodaynews.com\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/gospeltodaynews.com\/index.php?rest_route=\/wp\/v2\/users\/8"}],"replies":[{"embeddable":true,"href":"https:\/\/gospeltodaynews.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=8579"}],"version-history":[{"count":1,"href":"https:\/\/gospeltodaynews.com\/index.php?rest_route=\/wp\/v2\/posts\/8579\/revisions"}],"predecessor-version":[{"id":8580,"href":"https:\/\/gospeltodaynews.com\/index.php?rest_route=\/wp\/v2\/posts\/8579\/revisions\/8580"}],"wp:attachment":[{"href":"https:\/\/gospeltodaynews.com\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=8579"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/gospeltodaynews.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=8579"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/gospeltodaynews.com\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=8579"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}